A clinical study involved middle-aged and older adults on a low-calorie diet
Why this trial matters: First bispecific + CD38 combo to show superior PFS and OS in Phase III in RRMM Potential new standard of care as early as second-line Demonstrates deep responses, high MRD-negativity, and durable outcomes First-line Strategies in BRAF V600E-Mutant mCRC: Real-World Evidence Signals Treatment Priorities In a real-world retrospective cohort of patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), frontline chemotherapy plus anti-VEGF therapy was associated with the longest survival outcomes, while BRAF-targeted strategies showed promising response rates, emphasizing the need for tailored therapy and prospective validation
Set to purvey innumerable premier treatments and products in the coming year and beyond, Belo remains at the forefront of beauty for all
To provide timely, complementary evidence, we conducted a comparison of tirzepatide and semaglutide in patients at low, moderate and high cardiovascular risk who were diagnosed with obesity and type 2 diabetes and subgroups with specific cardiovascular conditions
Our goal is to elevate the quality of life for each person, providing medications, IV & Vitamin treatments to support our patients in feeling their optimal selves
On the other hand, it has also been observed that patients with obesity have a chronic inflammatory state of low grade (59)